Study details
Enrolling now
Using New Blood Tests to Identify Long COVID
MaxWell Clinic, PLC
NCT IDNCT06311435ClinicalTrials.gov data as of Apr 2026
Target enrollment
224
Study length
about 2 years
Ages
18+
Locations
2 sites in IA, TN
What this study is about
This trial is testing if a new blood test can help identify people with long COVID. The test looks at RNA in the blood, and researchers are comparing it to healthy individuals and other conditions that cause similar symptoms. This will determine if this test can accurately distinguish between these groups.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.RNA Biomarker Blood Test
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
diagnostic